血清胃蛋白酶原Ⅰ、Ⅱ在老年慢性胃炎患者筛查中的意义

陈娴; 罗红波; 陈娴; 罗红波

doi:10.13898/j.cnki.issn.1000-2200.2016.12.023

[1]

ZHANG Y,WECK MN,SCHÖTTKER B,et al.Gastric parietal cell antibodies,Helicobacter pylori infection,and chronic atrophic gastritis:evidence from a large population-based study in Germany[J].Cancer Epidemiol Biomarkers Prev,2013,22(5):821.

[2]

DU Y,BAI Y,XIE P,et al.Chronic gastritis in China:a national multi-center survey[J].BMC Gastroenterol,2014,14(1):1630.

[3]

黄勤,房静远,于成功,等.慢性胃炎的临床与病理学诊断进展[J].胃肠病学,2013,18(2):65.

[4]

SHIOTANI A,HARUMA K,GRAHAM DY.Metachronous gastric cancer after successful Helicobacter pylori eradication[J].World J Gastroenterol,2014,20(33):11552.

[5]

许爱萍,王金湖,张珏,等.慢性胃炎患者血清胃蛋白酶原检测的临床意义[J].国际检验医学杂志,2014,35(4):480.

[6]

季霞,蔡建庭.大于70岁老年慢性胃炎患者血清胃蛋白酶原测定和意义[J].浙江医学,2015,9(1):42.

[7]

XU Q,DONG QG,SUN LP,et al.Expression of serum miR-20a-5p,let-7a,and miR-320a and their correlations with pepsinogen in atrophic gastritis and gastric cancer:a case-control study[J].BMC Clin Pathol,2013,13(1):1.

[8]

[9]

周军,车虎森,何雪琴,等.血清胃蛋白酶原Ⅰ、Ⅱ在慢性萎缩性胃炎筛查中的应用价值[J].疑难病杂志,2014,2(10):1073.

[10]

张炜,赵卫东,李伟,等.幽门螺杆菌感染与重度慢性萎缩性胃炎患者血清MG-7及胃蛋白酶原相关性研究[J].中国基层医药,2013,20(16):2525.

[11]

YOSHIDA T,KATO J,INOUE I,et al.Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer.[J].Int J Cancer,2014,134(6):1445.

[12]

KAWAI T,GOTODA T,MORIYASU F.Pepsinogen,atrophic gastritis and gastric cancer[J].Jpn J MHTS,2014,41(2):303.

[13]

EBULE IA,LONGDOH AN,PALOHEIMO IL.Helicobacter pylori infection and atrophic gastritis[J].Afr Health Sci,2013,13(1):112.

[14]

徐芳,应丽园,秦波,等.血清瘦素联合胃蛋白酶原检测在胃癌及其癌前病变中的临床意义[J].中国医师杂志,2014,9(2):79.

[15]

YOSHIDA T,KATO J,MAEKITA T,et al.Altered mucosal DNA methylation in parallel with highly active Helicobacter pylori-related gastritis[J].Gastric Cancer,2013,16(4):488.